| Metric | Current | Prior | YoY |
|---|---|---|---|
| Revenue | ¥4.3B | ¥4.2B | +2.9% |
| Operating Income | ¥-12.2B | ¥-10.8B | -12.5% |
| Ordinary Income | ¥-12.2B | ¥-10.9B | -11.2% |
| Net Income | ¥-10.5B | ¥-13.9B | +24.6% |
| ROE | -305.8% | -199.1% | - |
FY2025 consolidated results for Wintest Corporation show revenue of 4.29B yen (YoY +2.9%) with operating loss of -12.18B yen (prior -10.83B yen, deterioration of 12.5%), ordinary loss of -12.17B yen (prior -10.94B yen, deterioration of 11.2%), and net loss attributable to owners of -12.42B yen (prior -11.05B yen, deterioration of 12.4%). Despite modest revenue growth, profitability deteriorated significantly with gross profit at -4.91B yen (margin -114.5%) indicating severe product profitability challenges. Operating cash flow registered -7.51B yen and free cash flow -7.81B yen, reflecting continued cash consumption. Basic EPS stood at -23.45 yen (prior -25.27 yen, slight improvement of 7.2%) while book value per share declined to 6.40 yen from 15.12 yen YoY. The company forecasts a sharp turnaround with FY2026 revenue of 16.62B yen (+287.4% YoY) and operating income returning to positive 0.56B yen, though execution risks remain substantial given the current operating structure.
Revenue increased 2.9% YoY to 4.29B yen primarily driven by domestic sales growth to 1.68B yen (prior 1.10B yen, +52.2%) while China sales declined slightly to 2.42B yen from 2.63B yen. Geographic composition shifted with Japan representing 39.1% (prior 26.5%), China 56.5% (prior 63.0%), and new contribution from Taiwan at 16.1M yen. Major customer concentration remained high with top three customers accounting for 53.5% of revenue: Shanghai Jingjiwei Semiconductor 1.26B yen, Nagoya Scientific Instruments 0.60B yen, and Jiangsu Huicheng Photoelectric 0.43B yen. The fundamental issue was severe gross profit deterioration, with cost of sales expanding 21.7% to 9.20B yen far exceeding revenue growth, resulting in negative gross profit of -4.91B yen (gross margin -114.5% versus prior -81.3%). This indicates product pricing significantly below cost or substantial cost overruns in contract fulfillment. SG&A expenses decreased 2.3% to 7.28B yen (170% of revenue), with R&D expenses declining to 2.16B yen from 2.27B yen (50.4% R&D intensity). Operating loss expanded to -12.18B yen from -10.83B yen despite lower fixed costs due to the deteriorating gross margin. Non-operating items contributed marginal net expense of 5M yen, leaving ordinary loss at -12.17B yen. Extraordinary items included impairment loss of 0.31B yen (prior 0.09B yen) partially offset by reversal of subscription rights to shares of 0.09B yen, resulting in net loss of -12.42B yen. The performance pattern reflects revenue growth with profit deterioration, driven fundamentally by product-level profitability collapse overwhelming modest fixed cost improvements.
The company operates a single segment of semiconductor inspection equipment business, therefore segment-level operating profit breakdown is not applicable.
[Profitability] ROE at -305.8% (prior -94.6%) reflects severe net loss against eroding equity base. Operating margin deteriorated to -283.9% from -259.8% YoY with gross margin at -114.5% indicating fundamental product economics challenges. R&D intensity remained elevated at 50.4% of revenue, suggesting continued investment despite operating losses. [Cash Quality] Cash and deposits declined to 0.83B yen from 0.91B yen YoY. Short-term debt coverage by cash stands at 0.83x with short-term loans payable at 1.00B yen. Operating cash flow to net income ratio of 0.60 indicates weak cash conversion, with operating CF at -7.51B yen against net income of -12.42B yen. Days Sales Outstanding extended significantly to 180 days (prior 77 days) and Days Inventory Outstanding to 216 days (prior 116 days), reflecting working capital deterioration. [Investment Efficiency] Total asset turnover at 0.47x (prior 0.35x) improved modestly. Fixed asset turnover increased as revenue grew while fixed asset base remained stable. [Financial Health] Equity ratio declined sharply to 37.3% from 57.0% YoY as retained losses accumulated to -43.71B yen from -31.29B yen. Current ratio at 185.2% and quick ratio at 173.3% appear adequate for short-term liquidity. Debt-to-equity ratio at 0.50x (prior 0.34x) with total interest-bearing debt at 1.73B yen. Short-term liabilities represent 83.7% of total liabilities at 4.81B yen, indicating concentrated near-term obligations. Net debt position at 0.90B yen with limited cash buffer against debt service requirements.
Operating cash flow recorded -7.51B yen (prior -6.62B yen, deterioration of 13.4%) representing 0.60x of net income, indicating earnings quality concerns with cash consumption exceeding accounting losses. The operating CF subtotal before working capital changes stood at -7.44B yen, with working capital movements consuming additional cash: inventory decreased by 5.18B yen contributing positively, while trade receivables increased by 1.21B yen and payables increased by 0.94B yen. The substantial accounts receivable buildup (YoY +139.4% to 2.12B yen) despite modest revenue growth signals collection delays or extended credit terms, with DSO extending to 180 days. Investing cash flow totaled -0.30B yen primarily for intangible asset purchases of 0.29B yen with minimal CapEx of 0.01B yen. Financing cash flow contributed positive 6.67B yen, driven by short-term loan drawdown of 1.00B yen offset by long-term loan repayments of 0.32B yen and lease obligation payments of 0.01B yen, suggesting reliance on external financing to sustain operations. Free cash flow remained deeply negative at -7.81B yen. Cash position declined from 0.91B yen to 0.83B yen after considering FX translation effects of 1.07B yen gain. The cash flow profile reveals unsustainable operating cash burn requiring continuous external funding, with working capital expansion particularly in receivables exacerbating liquidity pressure.
Ordinary income of -12.17B yen versus operating income of -12.18B yen shows minimal non-operating net contribution of approximately 10M yen. Non-operating income totaled 0.06B yen comprising primarily interest income of 0.005B yen and subsidy income of 0.02B yen, while non-operating expenses of 0.05B yen included interest expense of 0.04B yen and commission fees. Non-operating items represent 1.4% of revenue, indicating limited impact from financial activities. The material gap between ordinary income and net income stems from extraordinary items totaling net loss of 0.22B yen, primarily impairment loss of 0.31B yen partially offset by reversal of subscription rights of 0.09B yen, classified as non-recurring factors. Comprehensive income at -10.48B yen versus net income of -10.49B yen shows negligible other comprehensive income of 1.94B yen from foreign currency translation adjustments, suggesting limited unrealized gains to improve headline earnings. Operating cash flow significantly lags net income at 0.60x ratio, indicating poor earnings quality with accruals buildup particularly in accounts receivable (increasing 1.21B yen) and inventory reduction (contributing 5.18B yen positively but from elevated prior levels). The earnings quality assessment reveals structurally challenged profitability with negative gross margins, minimal non-operating support, and weak cash conversion undermining reported accounting results.
Full-year FY2026 guidance projects revenue of 16.62B yen (YoY +287.4%), operating income of 0.56B yen (versus current -12.18B yen loss), and ordinary income of 0.52B yen, with forecasted EPS of 0.98 yen. Current period progress against this aggressive forecast stands at revenue 25.8% and operating income achievement requires dramatic turnaround from loss to profit. The guidance implies quarterly run-rate revenue of approximately 4.2B yen versus current full-year 4.3B yen, suggesting expectation of substantial order intake and shipment acceleration. Operating margin is expected to recover to 3.4% from -283.9%, requiring both revenue scale-up and fundamental gross margin improvement from current -114.5% to sustainable positive levels. Given current contract liabilities at near-zero (0.03B yen), forward revenue visibility appears limited without disclosed order backlog data. Key forecast assumptions per management commentary include expectation of large-scale order fulfillment and production normalization, though specific customer commitments or backlog levels remain undisclosed. The substantial deviation between current run-rate performance and forecast suggests either significant contracted but unshipped orders or highly optimistic sales pipeline assumptions, warranting investor scrutiny of order book transparency and gross margin recovery execution plans.
Annual dividend remains zero yen for both Q2 and year-end (prior year also zero), with no dividend forecast for FY2026. Given accumulated retained losses of -43.71B yen and negative free cash flow of -7.81B yen, dividend capacity is absent under current financial condition. Payout ratio is not applicable given net losses. No share buyback activities were disclosed during the period. Total shareholder return ratio stands at zero. Dividend policy outlook remains contingent on achieving sustained profitability and positive cash generation, with management forecasting zero dividend even under FY2026 recovery scenario projecting positive EPS of 0.98 yen, indicating conservative approach to capital allocation prioritizing balance sheet repair over shareholder distributions in the near term.
Customer concentration risk remains elevated with top three customers representing 53.5% of revenue, where Shanghai Jingjiwei Semiconductor alone accounts for 29.3% at 1.26B yen. Loss or significant order reduction from these major customers would materially impact revenue and further stress operating leverage. Product profitability and cost control risk is critical, evidenced by gross margin at -114.5% indicating products sold below fully-loaded cost. Without rapid pricing improvements, cost reduction, or product mix optimization, sustained losses will accelerate capital erosion threatening going concern status. Working capital and cash consumption risk is substantial with operating cash outflow of -7.51B yen and accounts receivable increasing 139% to 2.12B yen despite modest revenue growth. DSO extension to 180 days and DIO at 216 days signal deteriorating collection efficiency and inventory turnover, consuming scarce liquidity. Combined with short-term debt of 1.73B yen against cash of 0.83B yen, refinancing risk exists if operating improvements fail to materialize and external financing sources tighten.
[Industry Position] (Reference - Proprietary Analysis)
The semiconductor equipment industry typically exhibits higher profitability metrics than Wintest's current performance. Industry participants generally maintain positive operating margins ranging 10-25% and ROE in mid-single to double-digit positive territory during normal business cycles. Wintest's operating margin of -283.9% and ROE of -305.8% position the company substantially below industry standards, reflecting company-specific execution challenges rather than industry-wide trends. The semiconductor inspection equipment segment is capital-intensive with typical R&D intensity of 8-15% of revenue; Wintest's 50.4% R&D intensity is exceptionally high, suggesting either development-stage product portfolio or inefficient R&D spending relative to revenue generation. Industry median equity ratios typically range 50-70% for established equipment manufacturers; Wintest's 37.3% equity ratio after recent erosion places it in the lower quartile, indicating elevated financial risk. Current ratio industry norms of 200-300% for equipment manufacturers compare to Wintest's 185%, which is adequate but below stronger peers. The company's negative gross margins are highly atypical for commercial-stage equipment suppliers and signal fundamental product pricing or cost structure misalignment requiring urgent remediation to approach industry viability standards.
(Industry: Semiconductor Equipment Manufacturing, Comparison: Reference benchmarks from industry participants, Source: Proprietary analysis)
Structural profitability challenge represents the dominant investment consideration, with gross margin at -114.5% indicating products are being sold substantially below cost. This is unsustainable and requires immediate pricing action, cost restructuring, or product mix shift. Without visible gross margin recovery in coming quarters toward at least breakeven, the aggressive FY2026 turnaround forecast lacks credibility and equity value erosion will continue. Working capital deterioration is accelerating cash consumption beyond operating losses, with accounts receivable surging 139% YoY and collection cycles extending to 180 days. This pattern suggests either customer credit quality concerns or potentially aggressive revenue recognition, both warranting enhanced scrutiny. Management must demonstrate receivable collection improvement and inventory normalization to stabilize cash burn. Forecast execution risk is substantial, with management projecting revenue growth of 287% and return to profitability in FY2026 from current deep losses. Investors should demand transparent disclosure of contracted order backlog, customer advance payments, and specific gross margin improvement initiatives. Without contracted visibility supporting the revenue forecast and demonstrated pathway to positive unit economics, the guidance represents high-risk scenario planning rather than probable outcome. The 83% short-term liability concentration (4.81B yen) against cash of 0.83B yen creates refinancing pressure if operations do not improve rapidly, potentially requiring equity dilution or debt restructuring that would further impact shareholder value.
This report was automatically generated by AI analyzing XBRL earnings data as an earnings analysis tool. This is not a recommendation to invest in any specific security. Industry benchmarks are reference information compiled from publicly available earnings data. Please make investment decisions at your own responsibility and consult professionals as needed.